Studying the SARS-CoV-2 proteases with the Sapphire Biomolecular Imager

4 minute read

JOIN THE AZURE INSIDER CLUB

For the latest publications, promotions, and news on upcoming products sent weekly to your inbox

ASK A SCIENTIST

Got a question? Let us help! Describe the problem you’re having and one of our experts will reach out.

Researchers at the Wroclaw University of Science and Technology and their colleagues have recently published exciting work improving our understanding of the two proteases encoded by the SARS-CoV-2 genome, the main protease (Mpro) and the papain-like protease (PLpro). These proteases are required for viral gene expression and for viral replication, so they are attractive targets for antiviral drug development. In addition, PLpro can inhibit the host innate immune response via deubiquitination activity, so inhibition of this protease may provide another mechanism of antiviral activity.

In each publication, the scientists used hybrid combinatorial substrate libraries to understand the rules governing substrate specificity of these proteases. Then, these rules guided the design of activity-based probes and irreversible inhibitors for each protease.

To characterize binding of their compounds to the proteases and the deubiquitinase activity of PLpro, the authors took full advantage of the fluorescence detection capabilities of the Sapphire Biomolecular Imager.

Since the release of this publication, the Azure Sapphire has been succeeded by the new Azure Sapphire FL, which was designed to be the flexible choice in bringing precise quantitation of nucleic acids and proteins. Learn more.

In Science Advances, the group examined SARS-CoV-2 PLpro, designing and characterizing two inhibitors. Using a biotinylated ubiquitinated probe, they found no evidence for cross-reactivity between their inhibitors and human deubiquitinases, an important requirement for potential antiviral drugs targeted to this protease. The biotinylated probe, bound to proteins in cell lysates, was detected on blots using an Alexa Fluor 647¬–labeled streptavidin as a probe and imaging the blots with the Sapphire Imager. To study the deubiquitinase activity of SARS-CoV-2 PLpro, binding and cleavage of ubiquitin-containing substrates was detected in SYPRO Ruby-stained gels, also imaged using the Sapphire Imager.

In Nature Chemical Biology, the group focused on SARS-CoV-2 Mpro, designing an inhibitor that demonstrated significant antiviral activity against SARS-CoV-2 in a cell culture assay, and an activity-based fluorescent probe that could be used to visualize active Mpro in cells taken from patients with COVID-19 infection. To study the binding of their compounds to SARS-CoV-2 Mpro, compounds labeled with Cy5 or BODIPY were detected directly on blots. Biotinylated versions were detected using Alexa Fluor 647¬–labeled streptavidin as a probe.

This research spotlights numerous avenues for development of potential anti-coronavirus drugs and tools for disease characterization and diagnostics.

Have you published with an Azure instrument?

We’d love to read it! Email your publication to us and we’ll send you something for sharing.

With up to four solid state lasers as excitation sources, the Sapphire Biomolecular Imager provides the flexibility to detect a wide variety of fluorescent dyes, including near infrared. To learn more about the Sapphire and how it can improve your fluorescence imaging, contact us at info@azurebiosystems.com.

SOURCES

  1. Gruber, Christian C.; Steinkellner, Georg (2020): Comparative model of novel coronavirus 2019-nCoV protease Mpro. figshare. Dataset. https://doi.org/10.6084/m9.figshare.11752752.v5 licensed under CC BY 4.0.
  2. https://doi.org/10.1126/sciadv.abd4596
  3. https://doi.org/10.1038/s41589-020-00689-z

Let us show you just how easy getting good data can be. Fill out this form to be contacted by a life science expert today!

Check out recent blog posts

Shopping cart0
There are no products in the cart!
Continue shopping